Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Shareholders Equity (Quarterly): 16.20M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 16.20M |
March 31, 2023 | 21.49M |
December 31, 2022 | 26.68M |
September 30, 2022 | 29.55M |
June 30, 2022 | 21.16M |
March 31, 2022 | 26.17M |
December 31, 2021 | 33.44M |
September 30, 2021 | 44.22M |
June 30, 2021 | -22.17M |
March 31, 2021 | 2.938M |
December 31, 2020 | 18.11M |
September 30, 2020 | 26.88M |
June 30, 2020 | 38.91M |
March 31, 2020 | 55.35M |
December 31, 2019 | 78.23M |
September 30, 2019 | 86.00M |
June 30, 2019 | 107.75M |
March 31, 2019 | -57.61M |
December 31, 2018 | -41.56M |
September 30, 2018 | 25.12M |
June 30, 2018 | 43.99M |
March 31, 2018 | 77.98M |
December 31, 2017 | 97.01M |
September 30, 2017 | 120.42M |
June 30, 2017 | 81.15M |
Date | Value |
---|---|
March 31, 2017 | 95.65M |
December 31, 2016 | 98.18M |
September 30, 2016 | 91.53M |
June 30, 2016 | 113.17M |
March 31, 2016 | 82.46M |
December 31, 2015 | 81.68M |
September 30, 2015 | 92.16M |
June 30, 2015 | 107.40M |
March 31, 2015 | 46.96M |
December 31, 2014 | 60.27M |
September 30, 2014 | 26.75M |
June 30, 2014 | 38.65M |
March 31, 2014 | 12.02M |
December 31, 2013 | 19.10M |
September 30, 2013 | 1.756M |
June 30, 2013 | 5.473M |
March 31, 2013 | 7.248M |
December 31, 2012 | 6.638M |
September 30, 2012 | -4.062M |
June 30, 2012 | -6.714M |
March 31, 2012 | -9.560M |
December 31, 2011 | -8.268M |
September 30, 2011 | -13.33M |
June 30, 2011 | -12.75M |
March 31, 2011 | -13.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-22.17M
Minimum
Jun 2021
107.75M
Maximum
Jun 2019
35.94M
Average
26.88M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 5.845M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.99M |
Total Liabilities (Quarterly) | 7.790M |
Current Ratio | 2.775 |